Navigation Links
Pharmasset Receives $10 Million of Working Capital
Date:3/28/2008

nture debt finance company that offers senior and subordinated working capital to emerging technology companies in the information technology and life sciences industries. Horizon provides a compelling alternative to the restrictive structures offered by banks and corporate finance companies.

The Horizon management team has provided debt financing for more than 750 companies over the last 15 years representing more than $2.0 billion in commitments. Horizon has offices in Farmington, CT and Pleasant Hill, CA. For additional information, please go to http://www.HorizonTechFinance.com.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a 4-week Phase 1 clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.
Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: (609) 613-4125
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmasset Appoints Herbert J. Conrad as a Director
2. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
3. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
4. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
5. Pharmasset Reports Fiscal Year End 2007 Financial Results
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. Pharmasset to Present at Three Investor Conferences in November 2007
8. Pharmasset Accesses up to $30 Million of Working Capital
9. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
10. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
11. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq: C...iring,developingandcommercializingsignificantprodu...ayannouncedthatCraigA.Collard,PresidentandChiefExe...the21stAnnualPiperJaffrayHealthCareConferenceat3:3...otelinNewYorkCity. ,, Aliveaudioandarchivedwebc...
(Date:11/20/2009)...s have an opportunity to take the lead in two smal...ersity of Valencia (UV), working together with the...abric of the Spanish biotechnology industry. Their... have more clout than those in English-speaking co...plants has been overlooked by the leading countrie...
(Date:11/20/2009)...swire-FirstCall/ -- Dendreon Corporation (Nasdaq: ...g Administration (FDA) provided written acknowledg... Application (BLA) for PROVENGE® (sipuleucel-... Prescription Drug User Fee Act (PDUFA) date of Ma...on,s amended BLA. Dendreon is seeking licensure f...
(Date:11/20/2009)...ber 20 Karolinska Development AB t...EIF) has entered into a,co-investment agreement wi...aged by Karolinska Development and used to invest ...utical and medical technology companies. EIF,has a...fund. The agreement,represents EIF,s largest singl...
Breaking Biology Technology:Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
... <P , ,>J. Turner , GE Healthcare,... Competitive binding assays have been developed f... serine-threonine and tyrosine kinases. Based on e...hydrolysis of chemiluminescent substrate, HitHunte...can be read either on high-throughput imaging plat...
... , Key words: H 1 receptor • ...er • SPA Imaging Beads , , Hi...athophysiological roles in central and peripheral ...ells, it contributes to several biological process...nction of histamine is mediated via four G protein...
..., Introduction , CypHer5 TM is a ...fluorescent at pH 7.4 and maximally fluorescent at...ring internalization of cell surface receptors via...n (1, 2). , <P ,>In the assay, the rec...izing the tag is then labelled with CypHer5. Alter...
Other Biology Technology:Homogeneous, chemiluminescent kinase assay kits for assessing the functional activity of a broad range of serine-threonine and tyrosine kinases 2Homogeneous, chemiluminescent kinase assay kits for assessing the functional activity of a broad range of serine-threonine and tyrosine kinases 3Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System 2Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System 3Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System 4Development of a histamine H1 receptor binding assay using the LEADseeker Multimodality Imaging System 5The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 2The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 3The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 4The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 5The use of CypHer5 for receptor internalization studies in both a range of GPCRs and a non-GPCR 6
(Date:11/22/2009)... CINCINNATI -- Children exposed prenatally to tob...ticularly high risk for ADHD, according to researc...enter. , The study estimates that up to 35 perce... and 15 could be reduced by eliminating both of th...into up to 800,000 children , "Tobacco and lead...
(Date:11/22/2009)... A commonly inherited gene deletion can increase ...one marrow transplantation, an international team ...online issue of Nature Genetics . When the gene, ... but present in the recipient,s, transplants have ...ect known as graft-versus-host disease, in which i...
(Date:11/22/2009)... Scientists at the Brain Research Centre, a partn...ty of Medicine and Vancouver Coastal Health Resear... the mechanism by which brain cells die following ...at damage. The results of the study were recently ...ng a stroke, many brain cells continue to die even...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2Amaizing 3A Corn genome decoded 14937 1Amaizing 3A Corn genome decoded 14937 2Amaizing 3A Corn genome decoded 14937 3Amaizing 3A Corn genome decoded 14937 4Just 25 25 of Voters in Competitive 2010 Senate Races 26amp 3B 238220 3BMuch More Likely 26amp 3B 238221 3B to Support Pelosi Democrats Who Voted for 61865 1Just 25 25 of Voters in Competitive 2010 Senate Races 26amp 3B 238220 3BMuch More Likely 26amp 3B 238221 3B to Support Pelosi Democrats Who Voted for 61865 2Just 25 25 of Voters in Competitive 2010 Senate Races 26amp 3B 238220 3BMuch More Likely 26amp 3B 238221 3B to Support Pelosi Democrats Who Voted for 61865 3American Dental Association Petitions FDA to Classify Regulate Tooth Whitening Products 61863 1American Dental Association Petitions FDA to Classify Regulate Tooth Whitening Products 61863 2
...USTON (March 10, 2009) Finding molecules that blo...nsducer and activator of transcription) required s...mputers that compared the structure of the cancer-... a Baylor College of Medicine researcher in a repo... journal PLoS One (Public Library of Science ONE...
...search presented today at the International Scient...s that the upper range of sea level rise by 2100 c...ly more. In the lower end of the spectrum it looks... much less than 50 cm by 2100. This means that if ...ly and substantially, even the best case scenario ...
...ow do the many carnivorous animals of the Americas...ach other,s meal? , A possible answer comes from ...sity of California, Davis. Their large-scale analy..., but avoidance strategies themselves that have be...ores, influencing such factors as whether species ...
Other Biology News:Small molecules block cancer gene 2Rising sea levels set to have major impacts around the world 2Rising sea levels set to have major impacts around the world 3American carnivores evolved to avoid each other, new study suggests 2
... to study co-translational and initial post-transl...such as signal peptide cleavage, membrane insertio...mined by the translation of the appropriate mRNA i...nes. In addition, processing and glycosylation eve...
...sing Mo Bio luciferase assay. Mo Bio Laboratories...service that will allow you to certify your produc...le you to deliver them to your customers in a time...0-12 /l, which will allow you to directly compete ...
...s: Biomedical Photometrics Inc. (Waterloo, Ontario...a, Germany) have collaborated to develop a fluores.... The DNAscope AT is based on BPIs patented MACRO...y reads up to six ArrayTubes in sequence using a c...
...ehensive kinase analysis service utilizing high de...arrays synthesized on Paraflo microfluidic chips f...measurement of kinase kinetic activities, and drug...cludes preparation of your kinase sample, single o...
Biology Products: